These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1712591)

  • 21. A Chromosome 6, not Natural Killer Cell, Contribution to Radiation- and Bleomycin-Induced Lung Disease in Mice.
    Lemay AM; Haston CK
    Radiat Res; 2018 Dec; 190(6):605-611. PubMed ID: 30277853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung.
    Manoury B; Caulet-Maugendre S; Guénon I; Lagente V; Boichot E
    Int J Immunopathol Pharmacol; 2006; 19(3):471-87. PubMed ID: 17026855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
    Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
    Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
    Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
    J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fine mapping of the major bleomycin-induced pulmonary fibrosis susceptibility locus in mice.
    Bergeron ME; Stefanov A; Haston CK
    Mamm Genome; 2018 Oct; 29(9-10):670-679. PubMed ID: 30173367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis.
    Suzuki H; Aoshiba K; Yokohori N; Nagai A
    Cancer Res; 2003 Aug; 63(16):5054-9. PubMed ID: 12941834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of metalloproteinases on pulmonary fibrosis by bleomycin in rats].
    Liu X; Xu S; He B; Tan W
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):98-100. PubMed ID: 11820951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.
    Harrison JH; Lazo JS
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1185-94. PubMed ID: 2447265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleomycin hydrolase activity and cytotoxicity in human tumors.
    Lazo JS; Boland CJ; Schwartz PE
    Cancer Res; 1982 Oct; 42(10):4026-31. PubMed ID: 6179595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse models of bleomycin-induced pulmonary fibrosis.
    Walters DM; Kleeberger SR
    Curr Protoc Pharmacol; 2008 Mar; Chapter 5():Unit 5.46. PubMed ID: 22294226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats.
    Cross CE; Warren D; Gerriets JE; Wilson DW; Halliwell B; Last JA
    J Lab Clin Med; 1985 Oct; 106(4):433-8. PubMed ID: 2413151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
    Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM
    J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice.
    Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM
    J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammalian alpha-acetylglucosaminidase. Enzymic properties, tissue distribution, and intracellular localization.
    Weissmann B; Rowin G; Marshall J; Friederici D
    Biochemistry; 1967 Jan; 6(1):207-14. PubMed ID: 4291567
    [No Abstract]   [Full Text] [Related]  

  • 36. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
    Pardo A; Ruiz V; Arreola JL; Ramírez R; Cisneros-Lira J; Gaxiola M; Barrios R; Kala SV; Lieberman MW; Selman M
    Am J Respir Crit Care Med; 2003 Mar; 167(6):925-32. PubMed ID: 12468440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis.
    Sriram N; Kalayarasan S; Sudhandiran G
    Chem Biol Interact; 2009 Jul; 180(2):271-80. PubMed ID: 19497426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
    Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleomycin induces strain-dependent alterations in the pattern of epithelial cell-specific marker expression in mouse lung.
    Daly HE; Baecher-Allan CM; Barth RK; D'Angio CT; Finkelstein JN
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):303-10. PubMed ID: 9070353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of strain variation in murine bleomycin-induced pulmonary fibrosis.
    Schrier DJ; Kunkel RG; Phan SH
    Am Rev Respir Dis; 1983 Jan; 127(1):63-6. PubMed ID: 6185026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.